Nuclear EGFR Contributes to Acquired Resistance to Cetuximab

類似資料

• Erlotinib is a viable treatment for tumors with acquired resistance to cetuximab
  著者:: Brand, Toni M, 等
  出版事項: (2011)
• Dasatinib blocks cetuximab- and radiation-induced nuclear translocation of the epidermal growth factor receptor in head and neck squamous cell carcinoma
  著者:: Li, Chunrong, 等
  出版事項: (2010)
• Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab
  著者:: Brand, Toni M, 等
  出版事項: (2011)
• Sym004, a Novel EGFR Antibody Mixture, Can Overcome Acquired Resistance to Cetuximab
  著者:: Iida, Mari, 等
  出版事項: (2013)
• Epidermal growth factor receptor cooperates with Src family kinases in acquired resistance to cetuximab
  著者:: Wheeler, Deric L., 等
  出版事項: (2009)